Appili Therapeutics, Inc,

Canada Country flag Canada
Sector: Pharmaceuticals
Ticker: APLI
Factsheet Factsheet

Profitability Analysis of Appili Therapeutics, Inc, ( APLI | CAN)

The Profitability Score is a relevant measure for the assessment of a stock attractiveness. Appili Therapeutics, Inc, shows a Profitability Score of 6.00.
The Profitability Score for Appili Therapeutics, Inc, is significantly higher than its peer group's. This means that Appili Therapeutics, Inc, has a significantly higher profitability than its peer group.

Valuation
EV/EBITDA LastEV/EBITDA(e) 2024EV/EBITDA NTM
Appili Therapeutics, Inc,Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Pharmaceuticals0.886.416.60
S&P/TSX9.508.918.11
Canada-2.146.496.00
More...
Beta (Ref: S&P/TSX)
Levered betaUnlevered beta
1-YearN/AN/A
2-YearN/AN/A
3-YearN/AN/A
More...
Stock Perf excl. Dividends (in CAD)
APLIS&P/TSXRel. Perf.
Year-to-Date-14.3%N/AN/A
1-Week-14.3%N/AN/A
1-Month-25.0%N/AN/A
1-Year0.0%N/AN/A
3-Year-84.6%N/AN/A
5-Year-94.2%N/AN/A
More...
GPRV Analysis
Appili Therapeutics,...
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
International Peers - Appili Therapeutics, Inc,
Company NameCtryMarket
Cap.
last (mUSD)
Appili Therapeutics, In...CAN2.58
International Peers Median0.94
MODERNA INC.USA15 062
Organon & Co.USA3 841
HUTCHMED (China) Ltd.CYM2 902
Akeso, Inc.CYM7 364
Repare Therapeutics, In...CAN124
Net Sales Chart
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Appili Therapeutics, Inc,
  • S&P/TSX
More...

About Stock Profitability Analysis

Aggregated Profitability Score
In GPRV, the Aggregated Profitability Score is the average of the profitability indicators' scores.

EBIT Margin Historical
This is a weighted average of the Historical EBIT Margins.
Calculation: (using up to 5 years of historical data when available)
[EBIT Margin year N*5 + EBIT Margin year (N-1)*4 + EBIT Margin year (N-2)*3 + EBIT Margin year (N-3)*2 + EBIT Margin (N-4)] / 15

EBIT Margin NTM
This is an estimate for EBIT Margin over the Next Twelve Months.
Calculation:
EBIT NTM / Net Sales NTM using estimates consensus for EBIT and Net Sales

ROCE Historical
This is a weighted average of the Historical Returns On Capital Employed.
Calculation: (using up to 5 years of historical data when available)
[ROCE year N*5 + ROCE year (N-1)*4 + ROCE year (N-2)*3 + ROCE year (N-3)*2 + ROCE year (N-4)] / 15

ROE Last
ROE (Return on Equity) is one of the most widely used measures of how well a company is performing for its shareholders, as it indicates how much was earned for each unit invested by the owners. It is a relatively straightforward benchmark for investors to compare the company's use of its equity against other investments.
Calculation:
ROE=Net profit after preferred dividends (Last) / Average total equity for the last 2 years (in %)

Dividend Yield NTM
This is an estimate for Dividend Yield over the Next Twelve Months.
Calculation:
The median of dividend per share estimates divided by the last share price.